Oculis
Clinical trials sponsored by Oculis, explained in plain language.
-
New eye drop shows promise for diabetic vision loss
Disease control CompletedThis study tested whether OCS 01 eye drops can improve vision in people with diabetic macular edema, a condition that causes swelling in the back of the eye and can lead to vision loss. About 400 adults with diabetes and eye swelling received either the active eye drop or a place…
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated May 26, 2026 07:53 UTC
-
New drug shows promise for eye nerve inflammation
Disease control CompletedThis study tested a new drug called OCS-05 in 36 people with acute optic neuritis, a condition that causes sudden vision loss due to nerve inflammation in the eye. The main goal was to see if the drug is safe and tolerable compared to a placebo, while everyone also received stand…
Phase: PHASE2 • Sponsor: Oculis • Aim: Disease control
Last updated May 26, 2026 07:26 UTC
-
New eye drops show promise for diabetic vision loss
Disease control CompletedThis study tested whether OCS-01 eye drops can improve vision and reduce swelling in people with diabetic macular edema, a condition that causes blurred vision in people with diabetes. The trial involved 552 participants and compared the eye drops to a placebo. The goal was to se…
Phase: PHASE2, PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated May 22, 2026 13:52 UTC
-
New eye drop could ease pain and swelling after cataract surgery
Symptom relief CompletedThis study tested an eye drop called OCS 01 in 153 adults who had cataract surgery. The goal was to see if it could reduce eye inflammation and pain better than a placebo. Participants used the drops once or twice a day for a few weeks. The results help determine the best dose fo…
Phase: PHASE2 • Sponsor: Oculis • Aim: Symptom relief
Last updated May 22, 2026 14:02 UTC